Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration

Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration

Context: Ranibizumab and bevacizumab are used widely for treating patients with choroidal neovascular membrane (CNVM) secondary to age-related macular degeneration (AMD). Aims: To determine and compare the efficacy and safety of intravitreal ranibizumab and bevacizumab in treatment of CNVM due to AM...

Full description

Bibliographic Details
Main Authors:	Partha Biswas, Subhrangshu Sengupta, Ruby Choudhary, Subhankar Home, Ajoy Paul, Sourav Sinha
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2011-01-01
Series:	Indian Journal of Ophthalmology
Subjects:	Ahmed glaucoma valve hypotony post-penetrating-keratoplasty glaucoma tube extrusion scleral patch Ranibizumab bevacizumab choroidal neovascular membrane age-related macular degeneration intravitreal injection central macular thickness best corrected visual acuity
Online Access:	http://www.ijo.in/article.asp?issn=0301-4738;year=2011;volume=59;issue=3;spage=191;epage=196;aulast=Biswas

Similar Items

Observation of curative effect of glaucoma valve implantation and intravitreal Bevacizumab for neovascular glaucoma
by: Bing-Jian Lü, et al.
Published: (2014-08-01)

Intravitreal bevacizumab and Ahmed glaucoma valve implantation in patients with neovascular glaucoma
by: Hai-Tao Zhang, et al.
Published: (2014-10-01)

Intravitreal injection of methotrexate in an experimental rabbit model: Determination of pharmacokinetics
by: Ebru Bener Ozkan, et al.
Published: (2011-01-01)

Study of intravitreal injection of bevacizumab or lucentis before Ahmed glaucoma valve implantation on the treatment of neovascular glaucoma
by: Yong Liu, et al.
Published: (2015-12-01)

Application of the intravitreal Ranibizumab combined with retinal photocoagulation for the neovascular glaucoma
by: Fen-Dui Zhang, et al.
Published: (2015-05-01)

Intravitreal Aflibercept Therapy in Intravitreal Bevacizumab/Ranibizumab Treatment-resistant Exudative Age-related Macular Degeneration
by: Neslihan Sevimli, et al.
Published: (2023-09-01)

Intravitreal Ranibizumab Therapy for Choroidal Neovascularization Secondary to Pathological Myopia: 3 Year Outcome
by: İrfan Perente, et al.
Published: (2018-04-01)

Pupil cycle time and contrast sensitivity in type II diabetes mellitus patients: A pilot study
by: Hoyoung Lee, et al.
Published: (2011-01-01)

Treatment for neovascular glaucoma with Ranibizumab and trabeculectomy
by: Jian Zhang, et al.
Published: (2019-12-01)

Comparison of bevacizumab and ranibizumab in age-related macular degeneration:a systematic review and meta-analysis
by: Xiao-Yu Zhang, et al.
Published: (2014-04-01)

Intravitreal Bevacizumab injection combined duplex technique in treatment of neovascular glaucoma
by: Zheng-Jun Hu, et al.
Published: (2015-05-01)

A Case Report of Intravitreal Bevacizumab for Iris Metastasis of Small Cell Lung Carcinoma with Neovascular Glaucoma
by: Takako Hidaka, et al.
Published: (2018-08-01)

Evaluation of diabetic macular edema by using optical coherence tomography in patients underwent combined phacoemulsification and intravitreal ranibizumab injection versus patients underwent sequential intravitreal ranibizumab injection and phacoemulsification: an observational study
by: Mohamed T El-Behaidy, et al.
Published: (2023-01-01)

Microalbuminuria and low hemoglobin as risk factors for the occurrence and increasing severity of diabetic retinopathy
by: V K Ajoy Mohan, et al.
Published: (2011-01-01)

Clinical Efficacy of Preoperative and Intraoperative Intravitreal Ranibizumab as Adjuvant Therapy of Ahmed Glaucoma Valve Implantation Combined with Vitrectomy in the Management of Neovascular Glaucoma with Diabetic Vitreous Hemorrhage
by: Shuang Gao, et al.
Published: (2023-12-01)

Comparison of Corneal Endothelial Changes After a Single-Dose Injection of Bevacizumab or Ranibizumab
by: Fatih Horozoğlu, et al.
Published: (2013-12-01)

Neovascular events in eyes with central retinal vein occlusion undergoing serial bevacizumab or ranibizumab intravitreal injections: A retrospective review
by: Francis Char DeCroos, et al.
Published: (2014-01-01)

Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema
by: Santosh K Mahapatra, et al.
Published: (2024-01-01)

Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
by: Zhe-Li Liu, et al.
Published: (2013-04-01)

Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
by: Tuğba Aydoğan, et al.
Published: (2016-12-01)

Meta-analysis of intravitreal Ranibizumab injection combined with glaucoma drainage valve implantation in the treatment of neovascular glaucoma
by: Shuai-Zheng Chen, et al.
Published: (2020-11-01)

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex®) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema
by: Murat Garlı, et al.
Published: (2021-12-01)

Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema
by: Joel Hanhart, et al.
Published: (2015-02-01)

Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
by: Pukhraj Rishi, et al.
Published: (2011-01-01)

Comparison of ranibizumab and bevacizumab in neovascular age-related macular degeneration
by: Huseyin Serdarogullari, et al.
Published: (2014-05-01)

Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
by: Hamidreza Torabi, et al.
Published: (2018-01-01)

Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
by: Chiung-Yi Chiu, et al.
Published: (2021-01-01)

Characteristics of macular edema in behcet disease after intravitreal bevacizumab injection
by: Fariba Ghassemi, et al.
Published: (2017-01-01)

Scleral abscess after intravitreal bevacizumab and triamcinolone injection
by: Preetam M Samant, et al.
Published: (2013-01-01)

6-weekly bevacizumab versus 4-weekly ranibizumab for neovascular age-related macular degeneration: a 2-year outcome
by: Patrick J Chiam, et al.
Published: (2016-04-01)

Clinical therapeutic effects of Aflibercept or Ranibizumab combined with Ahmed glaucoma valve implantation on neovascular glaucoma
by: Peng-Yi Zhou, et al.
Published: (2022-06-01)

Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma
by: Jin-Tao Sun, et al.
Published: (2017-03-01)

Application of Ranibizumab at perioperative period of compound trabeculectomy in patients with neovascular glaucoma
by: Su-Ying Qin, et al.
Published: (2016-01-01)

Intravitreal Ranibizumab for Diabetic Macular Edema Patients with Good Baseline Visual Acuity: A Real-Life Study
by: Abdullah Ozkaya, et al.
Published: (2017-10-01)

The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs
by: Berker Bakbak, et al.
Published: (2016-01-01)

Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study
by: Rajvardhan Azad, et al.
Published: (2012-01-01)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
by: Thomas BJ, et al.
Published: (2016-08-01)

Report of intravitreal injection of Ranibizumab for macular edema caused by central retinal vein occlusion
by: Jing-Yi Lai, et al.
Published: (2016-04-01)

Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
by: Alex Yuan, et al.
Published: (2014-02-01)

Transient painful vision loss due to hypotony after an intravitreal injection in a previously vitrectomized eye
by: Amer F. Alsoudi, et al.
Published: (2022-06-01)